Superoxide dismutase, aging, and degenerative disease

Free Radical Biology and Medicine

Volumn 17, Issue 3, 1994, Pages 249-258

  Warner, Huber R ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Aging; Amyotropic lateral sclerosis; Antioxidant defense; Free radical; Life span; Oxidative damage; Superoxide dismutase

Indexed keywords

FREE RADICAL; SUPEROXIDE DISMUTASE;

AGING; AMYOTROPHIC LATERAL SCLEROSIS; DEGENERATIVE DISEASE; HUMAN; LIFESPAN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW;

EUKARYOTA;

EID: 0028109191     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/0891-5849(94)90080-9     Document Type: Review

References (93)

1. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
2. Superoxide radical inhibits catalase
3. Inactivation of glutathione peroxidase by superoxide radical
4. ALS, SOD and peroxynitrite
5. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds
6. Copper, zinc superoxide dismutase catalyses hydroxyl radical production from hydrogen peroxide
7. Cellular clones and transgenic mice overexpressing copper-zinc superoxide dismutase: Models for the study of free radical metabolism and aging
8. Absence of electron transport (Rho° State) restores growth of a manganese-superoxide dismutase-deficient Saccharomyces cerevisiae in hyperoxia: Evidence for electron transport as a major source of superoxide generation in vivo
9. Aging: A theory based on free radical and radiation chemistry
10. Superoxide dismutase activity in two different wild-type strains of Drosophila melanogaster
11. Genetically determined conidial longevity is possitively correlated with superoxide dismutase, catalase, glutathione peroxidase, cytochrome c peroxidase and ascorbate free radical reductase activities in Neurospora crassa
12. 2, and basal and maximum aerobic capacity
13. Relationship between antioxidant defenses and longevity in different mammalian species
14. Unique increase of superoxide dismutase level in brains of long living mammals
15. Antioxidants and aging
16. Changes in the expression of superoxide dismutase and catalase as a function of age and dietary restriction
17. Influences of dietary restriction and age on liver enzyme activities and lipid peroxidation in mice
18. Overview: Mechanisms of antioxidant action on life span
19. Studies on catalase, glutathione peroxidase and superoxidismutase in aging cells of Paramecium tetraurelia
20. Effect of age on superoxide dismutase, catalase, glutathione reductase, inorganic peroxides, TBA-reactive material, GSH/GSSG, NADPH/NADP+ and NADH/NAD+ in Drosophila melanogaster
21. Aging and resistance to oxidative damage in Caenorhabditis elegans
22. Effect of aging on pulmonary superoxide dismutase
23. Antioxidant enzyme activities in heart and skeletal muscle of rats of different ages
24. Effect of age on the expression of antioxidant enzymes in male Fischer F344 rats
25. Superoxide dismutase in the rat and mouse as a function of age and longevity
26. Sex-dependent differences in the effects of aging on antioxidant defense mechanisms of rat liver
27. Effect of aging on enzymatic antioxidant defenses in rat liver mitochondria
28. Differential changes in superoxide dismutase activity in brain and liver of lld rats and mice
29. Antioxidant defences and peroxidation in liver and brain of aged rats
30. Age-related changes in antioxidant enzymes and prooxidant generation in tissues of rat with special reference to parameters in two insect species
31. Superoxide dismutase activities in aging rat brain
32. Age dependence of the level of the enzymes involved in the protection against active oxygen species in the rat brain
33. Antioxidant enzymatic systems in neuronal and glial cell-enriched fractions of rat brain during aging
34. Age-related changes in lipid peroxidation and protective enzymes in the central nervous system
35. Age-related changes in Cu,Zn superoxide dismutase, Se-dependent and -independent glutathione peroxidase and catalase activities in specific areas of rat brain
36. Increased superoxide dismutase activity in aged human cerebrospinal fluid and rat brain determined by electron spin resonance spectrometry using the spin trap method
37. Free radical scavenging systems and the effect of peroxide damage in aged human skin fibroblasts
38. Increased life-span of age-1 mutants in Caenorhabditis elegans and lower Gompertz rate of aging
39. Laboratory evolution of postponed senescence in Drosophila melanogaster
40. Multiple Genetic Mechanisms for the Evolution of Senescence in Drosophila melanogaster
41. The effect of superoxide dismutase alleles on aging in Drosophila
42. Overexpression of Cu-Zn superoxide dismutase in Drosophila does not affect life-span
43. Expression of bovine superoxide dismutase in Drosophila melanogaster augments resistance to oxidative stress
44. Effects of Cu-Zn superoxide dismutase overexpression on life span and resistance to oxidative stress in transgenic Drosophila melanogaster
45. Relationship of resistance to oxygen free radicals to CuZn-superoxide dismutase in transgenic, tranfected and trisomic cells
46. Cold-induced brain edema and infraction are reduced in transgenic mice overexpressing CuZn-superoxide dismutase
47. Reduced neurotoxicity in transgenic mice overexpressing human copper-zinc-superoxide dismutase
48. Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase
49. Transgenic mice with increase Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6 tetrahydropyridine-induced neurotoxicity
50. Down's syndrome: Abnormal neuromuscular junction in tongue of transgenic mice with elevated levels of human Cu/Zn-superoxide dismutase
51. Down's syndrome: Morphological remodelling and increased complexity in the neuromuscular junction of transgenic CuZn-superoxide dismutase mice
52. Human Mn-superoxide dismutase in pulmonary epithetial cells of transgenic mice confers protection against oxygen injury
53. The balance between Cu,Zn-superoxide dismutase and catalase affects the sensitivity of mouse epidermal cells to oxidative stress
54. Expression of transfected human Cu/Zn superoxide dismutase gene in mouse L cells and NS20Y neuroblastoma cells induces enhancement of glutathione peroxidase activity
55. Overproduction of human CuZn superoxide dismutase in transfected cells: Extenuation of paraquat-mediated cytotoxicity and enhancement of lipid peroxidation
56. Alteration of endogenous glutathione peroxidase, manganese superoxide dismutase, and glutathione transferase activity in cells transfected with a copper-zinc superoxide dismutase expression vector
57. 4-Hydroxynonenal content lower in brain of 25 month old transgenic mice carrying the human CuZn superoxide dismutase gene than in brains of their nontransgenic littermates
58. Impaired neurotransmitter uptake in PC12 cells overexpressing human Cu/Zn superoxide dismutase implication for gene dosage effects in Down syndrome
59. The linkage of genes for the human interferon-induced antiviral protein and indophenol oxidase-B traits to chromosome G-21
60. Copper/zinc superoxide dismutase activity in trisomy 21 by translocation
61. Molecular definition of a region of chromosome 21 that causes features of the Down syndrome phenotype
62. Amyotrophic lateral sclerosis and structural defects in CuZn superoxide dismutase
63. Peroxynitrite-mediated tyrosine nitration catalysed by superoxide dismutase
64. Isolation of superoxide dsimutase mutants in Escherichia coli: is superoxide dismutase necessary for aerobic life?
65. A yeast mutant lacking mitochondrial manganese-superoxide dismutase in hypersensitive to oxygen
66. Null mutation of copper/zinc superoxide dismutase in Drosphila confers hypersensitivity to paraquat and reduced longevity
67. A male infant with monosomy 21
68. A female infant with monosomy 21
69. Full monosomy 21: A clinically recognizable syndrome?
70. Partial monosomy 21, diminished activity of superoxide dismutase, and pulmonary oxygen toxicity
71. − syndrome with half normal SOD-1 activity
72. Monosomy 21 syndrome: Further delineation including clinical, neuropathological, cytogenetic and biochemical studies
73. Dosage effects for superoxide dismutase-1 in nucleated cells aneuploid for chromosome 21
74. Role of nutrients in delaying cataracts
75. Oxidants, antioxidants and the degenerative diseases of aging
76. Influence of antioxidant vitamins on LDL oxidation
77. Current status of antioxidant therapy
78. Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells
79. Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma
80. Induction of manganese superoxide dismutase in cultured human trophoblast during in vitro differentiation
81. Does superoxide underlie the pathogenesis of hypertension?
82. Redox redux: The control of oxidative stress responses
83. Transcriptional regulator of oxidative stress-inducible genes: Direct activation of oxidation
84. Escape from redox regulation enhances the transforming activity of Fos
85. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1
86. Modulation of transcription factor NF-κB binding activity by oxidation-reduction in vitro
87. Induction of superoxide dismutase by oxygen in neonatal rat lung
88. Differential regulation of antioxidant enzymes in response to oxidants
89. Induction of superoxide dismutase in leukocytes by paraquat: Correlation with age and possible predictor of longevity
90. Induction of manganous superoxide dismutase by tumor necrosis factor: Possible protective mechanism
91. Manganous superoxide dismutase is essential for cellular resistance to cytoxicity of tumor necrosis factor
92. Tumor recrosis factor-α activates nuclear factor κB and induces manganous superoxide dismutase and phosphodiesterase mRNA in human papillary thyroid carcinoma cells
93. Expression of Human Cu-Zn Superoxide Dismutase Gene in Transgenic Mice: Model for Gene Dosage Effect in Down Syndrome